Brain stimulation therapies involve activating or touching the brain directly with electricity, magnets, or implants to treat depression and other disorders. Electroconvulsive therapy is the most researched stimulation therapy and has the longest history of use. Other stimulation therapies discussed here—vagus nerve stimulation, deep brain stimulation, Ojemann direct cortical stimulation, and transcranial direct current stimulation—are newer, more experimental methods.
The market for neuro-technology products is poised to become one of the most dramatic growth areas of the 21st Century. Spurred on by medical developments and discoveries that cure disease, alleviate suffering, and generally improve the quality of life, many leading research institutions and healthcare firms have gained the world’s attention and respect in recent years. Within biomedical technology, the field of neuro-technology stands out for its promise of restoring human brain function, and for transferring biomedical concepts and processes to the industrial and information processing sectors.
The fields of neuro-technology and neuroscience offer the promise of generating significant capital interest and funding, despite the current depressed state of new technology ventures. Investors will be looking for new opportunities in markets related to neuroscience. Neuro-technology, with its promise and proven record at such tasks as restoring hearing to deaf patients and hand function to quadriplegics, offers a clear opportunity.
In view of the forgoing, this invention is developed to provide an implantable electrode assembly for stimulating a patient’s brain with pulses of electric current.